中财网 中财网股票行情
恒瑞医药(600276)财务分析指标    年份：
截止日期2025-03-312024-12-312024-09-302024-06-302024-03-31
营业总收入(万元)720561.112798460.532018930.381360073.41599753.39
营业收入(万元)720561.112798460.532018930.381360073.41599753.39
营业总成本(万元)512854.182101154.141508997.92975600.04442578.23
营业成本(万元)106866.25384817.74283318.27187330.3794284.94
净利润(万元)187650.22633417.49460807.66343097.53136278.73
归属于母公司的净利润(万元)187405.55633652.70461957.59343174.81136892.92
营业利润(万元)208598.09749063.20534529.05398477.61163600.88
利润总额(万元)207560.37716969.00508674.02375160.01150251.08
少数股东损益(万元)238.6446.76-324.57-361.57-144.06
基本每股收益(元)0.30(元)1.00(元)0.73(元)0.54(元)0.21(元)
稀释每股收益(元)0.30(元)1.00(元)0.73(元)0.54(元)0.21(元)
非经常性损益(万元)1076.8915856.05-----7155.10
扣除非经常性损益后净利润(万元)186328.66617796.65461631.48349005.15144048.03
总资产(万元)5129278.175013564.534833809.944818136.004634000.14
总负债(万元)374301.26404539.46400658.07499422.39390064.60
归属于母公司股东权益合计(万元)4698705.954551986.194376790.884262224.284187350.48
股东权益合计(万元)4754976.914609025.074433151.874318713.624243935.53
实收资本(股本)(万元)637900.23637900.23637900.23637900.23637900.23
资本公积(万元)285387.48318807.26322235.23316704.24311256.51
未分配利润(万元)3573958.453386552.903214857.793096075.013017169.96
经营活动产生的现金流量净额(万元)55517.41742275.30458544.60303275.48125459.89
经营活动现金流入小计(万元)630193.652846888.172054679.711383831.96613605.14
经营活动现金流出小计(万元)574676.242104612.871596135.111080556.47488145.25
投资活动产生的现金流量净额(万元)-53167.76-191198.57-187344.65-152359.24-75039.02
投资活动现金流入小计(万元)17035.4367989.2225122.104108.131063.16
投资活动现金流出小计(万元)70203.19259187.79212466.75156467.3776102.19
筹资活动产生的现金流量净额(万元)-66105.92-155059.00-150652.41-13856.75-1813.46
筹资活动现金流入小计(万元)--79990.9479990.9479990.94--
筹资活动现金流出小计(万元)66105.92235049.94230643.3493847.691813.46
期末现金及现金等价物余额(万元)2363116.362423910.212145578.022163628.072073939.02
最后修改日期2025-04-252025-03-312024-10-242024-08-212024-04-18
↑返回页顶↑

转至恒瑞医药（600276）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。